CHIME suggests that CMS allow eligible professionals, eligible hospitals and critical access hospitals to demonstrate meaningful use during a 90-day reporting period for their first payment year to give them time to better prepare. “To allow adequate time for application development, provider adoption and testing, CMS should follow the precedent set in Stage 1,” CHIME said.
The organization also urged ONC to require certification of EHR products for all clinical quality measures in each setting. “Through our experiences with Stage 1, we found that although EHR products were able to automatically produce CQM reports, the data was inaccurate and largely incomparable across different providers,” said CHIME.
In the comments, CHIME also makes recommendations for the 42 proposed objectives for ambulatory and inpatient settings of care. “The menu set for both EPs and hospitals is quite small in relation to the minimum number that would need to be met, thereby providing relatively few options for EPs and hospitals,” the comment letter said. “A number of the proposed menu set objectives and measures would have non-trivial cost implications for EPs and hospitals.” CHIME urged CMS to assess the number and feasibility of menu options for the average physician practice or hospital in finalizing its Stage 2 rule.
More Articles on Stage 2 Meaningful Use:
AHA Expresses Concern Over CMS Proposed Stage 2 Meaningful Use Rule
Report: Despite High Hospital Adoption Rates, Meaningful Use Requirements Seen as Challenge
Physicians Collect More Medicare Meaningful Use Payments in February Than Hospitals
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
